Over the 3 to 12 months following catheter ablation, patients who received metformin had greater freedom from recurrent ...

NEW ORLEANS, LA—Sodium-glucose cotransporter 2 (SGLT2) inhibition does not seem to be a solution to the problem of arrhythmia ...

A minimally invasive heart procedure to correct irregular heart rhythms called catheter ablation may reduce the risk of ...

OCEAN was an open-label trial conducted in Australia, Belgium, Canada, China, Germany, and Israel. Eligible participants had ...

Successful catheter ablation resulted in a low risk of stroke associated with atrial fibrillation (AFib), a type of irregular ...

A minimally invasive heart procedure to correct irregular heart rhythms called catheter ablation may reduce the risk of ...

Background: Observational studies have suggested that sodium-glucose cotransporter 2 inhibitors (SGLT2i) are associated with a lower risk of atrial fibrillation (AF) recurrence after catheter ablation ...

People with atrial fibrillation (AFib) and obesity may have fewer episodes of AFib after ablation if they take the diabetes ...

Adults with atrial fibrillation with overweight or obesity were less likely to experience recurrent atrial arrhythmia when ...

OCEAN, said Albert, provides important risk-benefit data that doctors can now use in discussions with their patients. For ...

Personalized digital models provide doctors with a roadmap to precisely target life-threatening cardiac arrhythmias.